申请人:Merck Sharp & Dohme Corp.
公开号:US07935712B2
公开(公告)日:2011-05-03
The invention relates to a compound of a formula (I): or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.
本发明涉及一种式(I)的化合物,或其药学上可接受的盐或酯,用作治疗各种与ACC相关的疾病的治疗剂。